Nammi Therapeutics

Operator of an immunotherapy company intended to provide improved treatment of cancer. The company combines immune-modulating prodrugs into lipid nanoparticles for selective delivery to tumors as well...

Healthcare

Los Angeles, CA, United States

Founded 2018

8 employees

Website

Valuation

$75M

Market implied

Share Price

N/A

Total Raised

$66.5M

Last Round

N/A

Investors

+3 other investors

View all 3 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Nammi Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required